[1]
A. J. Al-Shemmary, “HEMATOLOGICAL AND BIOCHEMICAL PROFILES IN RHEUMATOID ARTHRITIS PATIENTS UNDERGOING METHOTREXATE, RITUXIMAB, AND COMBINATION THERAPY”, JMGCB, vol. 2, no. 7, pp. 334–340, Jul. 2025.